Screening and Management of Lynch Syndrome: The Chinese Experience

Clin Colon Rectal Surg. 2023 May 3;36(6):369-377. doi: 10.1055/s-0043-1767706. eCollection 2023 Nov.ABSTRACTLynch syndrome (LS), caused by germline mutations in the mismatch repair genes, is the most common hereditary colorectal cancer. While LS is also associated with various cancers, early detection of the proband is meaningful for tumor prevention, treatment, and familial management. It has been a dramatic shift on the screening approaches for LS. As the rapid development of the molecular biological methods, a comprehensive understanding of the LS screening strategies will help to improve the clinical care for this systematic disease. The current screening strategies have been well validated but mainly by evidence derived from western population, lacking consideration of the ethnic heterogeneity, which hampers the universality and clinical application in China. Hence, this review will focus on the Chinese experience in LS screening, aiming to help better understand the ethnic diversity and further optimize the screening strategies.PMID:37795465 | PMC:PMC10547539 | DOI:10.1055/s-0043-1767706
Source: Clinical Colorectal Cancer - Category: Cancer & Oncology Authors: Source Type: research